- Easy Tracking In The Watchlist
Is ImmunoCellular Therapeutics Ltd stock still a buy after falling -43.98% on Friday?
(Updated on Jul 31, 2026)
The ImmunoCellular Therapeutics Ltd stock price fell by -43.98% on the last day (Friday, 31st Jul 2026) from $0.235 to $0.132. During the last trading day the stock fluctuated 0% from a day low at $0.132 to a day high of $0.132. The price has been going up and down for this period, and there has been a -12.27% loss for the last 2 weeks. Volume has increased on the last day by 14 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 14 thousand shares were bought and sold for approximately $1.83 thousand.
Given the current short-term trend, the stock is expected to rise 64.49% during the next 3 months and, with a 90% probability hold a price between $0.216 and $0.578 at the end of this 3-month period.
IMUC Signals & Forecast
There are few to no technical positive signals at the moment. The ImmunoCellular Therapeutics Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.202 and $0.210. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 09, 2026, and so far it has fallen -51.26%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). ImmunoCellular Therapeutics Ltd gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for ImmunoCellular Therapeutics Ltd stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.125 and $0.110. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ImmunoCellular Therapeutics Ltd finds support just below today's level at $0.125. If this is broken, then the next support from accumulated volume will be at $0.110 and $0.110.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week, the stock has had daily average volatility of 0.0168%.
Our recommended stop-loss: $0.124 (-5.40%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 36 days ago.)
Trading Expectations (IMUC) For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect ImmunoCellular Therapeutics Ltd to open at $0.132, and during the day (based on 14 day Average True Range), to move between $0.118 and $0.145, which gives a possible trading interval of +/-$0.0269 (+/-22.74%) up or down from last closing price. If ImmunoCellular Therapeutics Ltd takes out the full calculated possible swing range there will be an estimated 22.74% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.134 (1.60%) than the support at $0.125 (5.02%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is ImmunoCellular Therapeutics Ltd stock A Buy?
ImmunoCellular Therapeutics Ltd holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
0.000
Hold/Accumulate
Unchanged
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on August 3, 2026 - $0.132 ( 0%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
IMUC Performance
Trading levels for IMUC
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.132 | - |
| R2 | 0.132 | - |
| R1 | 0.132 | - |
| Price | 0.132 | |
| S1 | 0.132 | - |
| S2 | 0.132 | - |
| S3 | 0.132 | - |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0.150 | 13.98% |
| R1 | 0.134 | 1.60% |
| Price | 0.132 | |
| S1 | 0.125 | -5.02% |
| S2 | 0.110 | -16.36% |
| S3 | 0.110 | -16.41% |
FAQ
Click here for our free guide on how to buy ImmunoCellular Therapeutics Ltd Stock.
Buy IMUC